SLRX
Salarius Pharmaceuticals Inc
NASDAQ: SLRX · HEALTHCARE · BIOTECHNOLOGY
$0.84
+29.23% today
Updated 2026-01-07
Market cap
$4.92M
P/E ratio
—
P/S ratio
18.12x
EPS (TTM)
$-24.24
Dividend yield
—
52W range
$1 – $25
Volume
2.4M
Salarius Pharmaceuticals Inc (SLRX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-1.40%
ROA
-0.70%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2014 | — | $-8.01M | — | — | — |
| 2015 | — | $-29.14M | — | — | — |
| 2016 | $1.01M | $-39.49M | 34.42% | -3,945.20% | -3,906.33% |
| 2017 | $1.27M | $-34.43M | 60.24% | -2,723.61% | -2,700.71% |
| 2018 | $838000.00 | $-21.92M | 48.57% | -2,634.13% | -2,615.99% |
| 2019 | $3.47M | $-6.94M | 100.00% | -238.53% | -200.18% |
| 2020 | $5.23M | $-7.35M | 100.00% | -148.78% | -140.49% |
| 2021 | $1.84M | $-12.77M | 98.96% | -696.27% | -693.84% |
| 2022 | $0.00 | $-31.61M | — | — | — |
| 2023 | $0.00 | $-12.54M | — | — | — |
| 2024 | $0.00 | $-5.58M | — | — | — |